Traumatic brain injury and spinal cord injury are two distinct but fundamentally similar types of acute insults to the central nervous system (CNS) that often culminate in death or cognitive and motor impairment. Over the past decade, researchers have tapped into research to discover the potential role being played by gut bacteria in CNS. After an acute CNS injury, the altered composition of the gut microbiota disturbs the balance of the bidirectional gut-brain axis, aggravating secondary CNS injury, motor dysfunctions, and cognitive deficits, which worsens the patient's prognosis. Some of the well-known therapeutic interventions which can also be used as adjuvant therapy for alleviating CNS injuries include, the use of pro and prebiotics, fecal microbiota transplantation, and microbial engineering. In this review, we aim to discuss the importance of gut microbes in our nervous system, anatomy, and signaling pathways involved in regulating the gut-brain axis, the alteration of the gut microbiome in CNS injuries, and the therapeutic strategies to target gut microbiomes in traumatic CNS injuries.
Keywords: Brain-derived neurotrophic factor (BDNF); Dopamine; Fecal microbiota transplantation; Gamma amino butyric acid (GABA); Gene therapy; Ghrelin; Gut-brain axis; Lactic acid; Leptin; Probiotics; Resveratrol; Serotonin; Spinal cord injury; Traumatic brain injury; Trimethylamine-N-oxide; Tryptophan.
Copyright © 2023. Published by Elsevier Inc.